Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 41.09 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 7.20 | Oscillator | Buy |
| Williams %R (14) | -98.75 | Oscillator | Buy |
| MACD (12, 26, 9) | -0.01 (Hist -0.06) | Oscillator | Strong Sell |
| Average Directional Index (14) | 19.49 (+DI 19.6 / -DI 23.2) | Trend | Neutral |
Current price $3.88
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| EMA 20 | 4.08 | MA | Strong Sell |
| SMA 20 | 4.15 | MA | Strong Sell |
| EMA 50 | 3.92 | MA | Sell |
| SMA 50 | 4.01 | MA | Strong Sell |
| SMA 200 | 3.55 | MA | Strong Buy |
| Dec 17, 20 |
| BMO Capital |
| downgrade |
| Market Perform |
| Underperform |
| Nov 25, 20 | Piper Jaffray | maintain | Neutral | Neutral |
| Nov 25, 20 | Bank of America | downgrade | Buy | Neutral |
| Nov 25, 20 | Ladenburg Thalmann | downgrade | Buy | Neutral |
| Nov 25, 20 | B of A Securities | downgrade | Buy | Neutral |
| Nov 25, 20 | Piper Sandler | downgrade | Neutral | Underweight |
| Nov 25, 20 | Piper Sandler | maintain | Neutral | Neutral |
| Nov 25, 20 | Stifel | downgrade | Hold | Sell |
| Nov 25, 20 | Piper Sandler | upgrade | Underweight | Neutral |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
FY2026 · 10-K disclosure
TTM vs. 5-year historical average (annual ratios)
| Metric | ACB | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -2.8x | 41.9x · sector 20.7x | Discount |
| Forward P/E (FY27E) | -22.2x | EPS est. -0.18 | Elevated |
| Price / Book | 0.6x | 0.6x | In line |
| Price / Sales | 1.2x | 1.2x | In line |
| EV / EBITDA | -3.7x | -3.6x | In line |
| Return on equity | -21.0% | — | Weak |
| Gross margin | 32.1% | 32.4% | In line |
| Debt / Equity | 0.04 | 0.27 | Conservative |
| Piotroski / Altman Z | 2/9 | Z -11.58 | Distress |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| SC14D9F/A | Oct 15, 2026 | 2026-10-15 09:48:38 | View |
| 6-K | Oct 14, 2026 | 2026-10-14 16:18:44 | View |
| 6-K | Oct 8, 2026 | 2026-10-08 08:16:07 | View |
| 6-K | Oct 7, 2026 | 2026-10-06 17:35:59 | View |
| SC14D9F/A | Oct 6, 2026 | 2026-10-06 17:15:51 | View |
| SC14D9F/A | Oct 6, 2026 | 2026-10-06 10:05:35 | View |
| SC14D1F/A | Oct 6, 2026 | 2026-10-06 09:43:58 | View |
| 425 | Oct 6, 2026 | 2026-10-06 08:38:49 | View |
| 6-K | Oct 6, 2026 | 2026-10-05 18:41:21 | View |
| SC14D9F/A | Sep 24, 2026 | 2026-09-24 16:37:56 | View |
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
Curaleaf TodayCURLFCuraleaf$7.80 +0.17 (+2.26%) As of 02:38 PM Eastern52-Week Range$5.40▼$15.15Price Target$6.00Add to WatchlistCuraleaf Holdings, Inc. OTCMKTS: CURLF is aggressively maneuvering to absorb Aurora Cannabis Inc. NASDAQ: ACB, leveraging an estimated 217% ex-cash premium to force a shareholder reckoning and bypass an entrenched board.
NASDAQ | TSX: ACB Revised Hostile Bid continues to significantly undervalue Aurora; fails to address concerns previously raised by the Board. Aurora's Special Committee is actively exploring strategic alternatives to maximize value for Aurora shareholders.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -0.13 | -0.05 | Beat 64.6% | $47.56M |
| Jun 11, 2026 | -0.07 | -0.71 | Miss -914.1% | $60.98M |
| Feb 4, 2026 | 0.10 | 0.02 | Miss -75.9% | $68.59M |
| Nov 5, 2025 | 0.03 | -0.65 | Miss -2274.8% | $64.88M |
| Aug 6, 2025 | 0.18 | -0.19 | Miss -205.6% | $72.00M |
| Jun 18, 2025 | 0.11 | -0.24 | Miss -321.1% | $62.91M |